I am glad you think Mente is a great product. I think so too. If it is a scam, it would not start its multi site trial here in Australia where any publicity will affect the listed company directly, positively or negatively.
We have to put some time line in perspective. It is only in August that we have our first batch of product in the market. As Europe is on summer holiday, activities was here in various cities, introducing Mente Autism to the Autism Centres and Schools, on top of the roadshows to the investors. That took it till about 20th August.
Autism Schools and Centres will not endorse any new device immediately as there are just too many charlatan products out there as there is lots of money to be made in Autism. Multi site trials are on going now, they want to see evidence, only upon satisfaction with the product before they would give their recommendations to the bigger populations of their students. So how many weeks has it been? 3 perhaps.
Europeans only have returned to work in September, multi site trials are now able to be conducted in the various countries. I would say the main sale now is in the Italian market.
I would also note that these multi site trials will not necessarily take the 12 weeks, nor does it need the same level of analysis and reporting as the USA clinical trial.
So to quote what you wrote:
"...but clearly its either not striking the right chord with users (maybe not user friendly enough) or management particularly marketing management has no idea. the market is certainly there but results are sadly lacking."
It is just unfair and impatient.
- Forums
- ASX - By Stock
- Expensive Board and Management asleep at the wheel.
I am glad you think Mente is a great product. I think so too. If...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.6¢ |
Change
-0.003(4.35%) |
Mkt cap ! $64.55M |
Open | High | Low | Value | Volume |
6.9¢ | 6.9¢ | 6.6¢ | $73.27K | 1.107M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7106 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 269492 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 589299 | 0.070 |
1 | 36231 | 0.069 |
5 | 240000 | 0.068 |
2 | 255000 | 0.067 |
3 | 262000 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 100000 | 1 |
0.074 | 40000 | 1 |
0.075 | 738582 | 2 |
0.076 | 90000 | 1 |
0.077 | 190000 | 3 |
Last trade - 15.03pm 25/11/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online